Max Healthcare Institute Ltd
MAXHEALTH
株式のランク
#2269
Max Healthcare Institute Limited provides medical and healthcare services in... Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
株価
$9.02
最終同期: 2026-10-21
時価総額
$8.78B
変化（1日）
-1.52%
変化（1年）
-34.05%
国
IN
取引 Max Healthcare Institute Ltd (MAXHEALTH)
カテゴリー
Healthcare
Max Healthcare Institute Ltd（MAXHEALTH）のP/E比率
October 2026 時点のP/E比率 TTM 57.76
Max Healthcare Institute Ltd の最新の財務報告および株価によると、現在の P/E (TTM) は 57.76 です。2024 年末時点での P/E は 75.05 でした。
Max Healthcare Institute Ltd の P/E 比率の履歴（2014 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 57.76 | -41.32% |
| 2025 | 98.42 | 31.15% |
| 2024 | 75.05 | 93.54% |
| 2023 | 38.78 | -30.25% |
| 2022 | 55.59 | -143.05% |
| 2021 | -129.12 | -291.58% |
| 2020 | 67.40 | -103.38% |
| 2019 | -1.99K | 854.56% |
| 2018 | -208.95 | -131.54% |
| 2017 | 662.60 | -345.66% |
| 2016 | -269.72 | 105.16% |
| 2015 | -131.47 | 84.92% |
| 2014 | -71.10 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 15.70 | -72.81% |
US
|
|
| - | - |
DE
|
|
| 10.40 | -82.00% |
US
|
|
| 32.07 | -44.47% |
SA
|
|
| 20.00 | -65.37% |
BR
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。